Clinical Trial S2013

#ClinicalTrial S2013 #ICHECKIT follows patients taking #immunotherapy and chemotherapy drugs for #cancer, to learn who is at risk for serious side effects. To learn more about S2013, visit SWOG.org/S2013. Or call 1-800-4-Cancer and ask about S2013.
@swog.org
#esocsm #gicsm

Clinical Trial S2013

The SWOG #ICHECKIT #cancer trial S2013 asks: Can we predict which cancer patients are most at risk for serious side effects from widely used immunotherapy drugs? To learn more, visit swog.org/S2013. Or call 1-800-4-Cancer and ask about S2013. #bcsm #ImmunoOnc #lcsm #gicsm

Trial S2013 I-CHECKIT

PI Krishna Gunturu, MD, of Hartford HealthCare Cancer Institute co-leads a reopened S2013 #ICHECKIT cancer trial. It’s developing a model to predict which patients are most likely to have serious adverse events from immune checkpoint inhibitor-based therapy. swog.org/clinical-trials/S2013 #ImmunoOnc